2,093
Views
14
CrossRef citations to date
0
Altmetric
Articles

Effects of huoxin formula on the arterial functions of patients with coronary heart disease

, , , , , , , , , & show all
Pages 13-20 | Received 11 Apr 2018, Accepted 06 Dec 2018, Published online: 14 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jia Ke, Meng-Ting Li, Shuyang Xu, Jianpeng Ma, Ming-Yuan Liu & Yan Han. (2023) Advances for pharmacological activities of Polygonum cuspidatum - A review. Pharmaceutical Biology 61:1, pages 177-188.
Read now
Yun Zhang, Jie Wang, Yong-Mei Liu, Yin-Ying Chen, Xiao-Chen Yang & Lian Duan. (2021) The Synergistic Effects of Astragalus mongholicus and Salvia miltiorrhiza on Coronary Heart Disease Identified by Network Pharmacology and Experiment. Drug Design, Development and Therapy 15, pages 4053-4069.
Read now
Jia He, Da Wo, En Ma, Qing Wang, Jinxiao Chen, Jun Peng, Weidong Zhu & Dan-ni Ren. (2021) Network pharmacology-based analysis in determining the mechanisms of Huoxin pill in protecting against myocardial infarction. Pharmaceutical Biology 59:1, pages 1189-1200.
Read now

Articles from other publishers (11)

Xianmei Li, Laifeng Zeng, Zhixin Qu & Fenghua Zhang. (2023) Huoxin pill protects verapamil-induced zebrafish heart failure through inhibition of oxidative stress-triggered inflammation and apoptosis. Heliyon, pages e23402.
Crossref
Saeed Aslani, Bahman Razi, Danyal Imani, Keyhan Mohammadi, Tannaz Jamialahmadi, Željko Reiner & Amirhossein Sahebkar. (2023) Effect of Statins on the Blood Lipid Profile in Patients with Different Cardiovascular Diseases: A Systematic Review with Meta-analysis of Randomized Clinical Trials. Current Medicinal Chemistry 30:32, pages 3702-3724.
Crossref
Lumin Tang, Xiang Li, Yu Qin, Xinyao Geng, Ruowen Wang, Weihong Tan & Shan Mou. (2022) The construction of oligonucleotide-cycloastragenol and the renoprotective effect study. Frontiers in Bioengineering and Biotechnology 10.
Crossref
YiWen LI, BinYu LUO, Jing CUI, MengMeng ZHU, Yue LIU, Hao XU, DaZhuo SHI & KeJi CHEN. (2022) Combination of disease and syndrome in coronary artery disease: prevention and treatment strategies. SCIENTIA SINICA Vitae 52:6, pages 797-811.
Crossref
Qing Wang, En Ma, Da Wo, Jinxiao Chen, Jia He, Jun Peng, Weidong Zhu & Dan‐ni Ren. (2021) Huoxin pill prevents acute myocardial ischaemia injury via inhibition of Wnt/β‑catenin signaling. Journal of Cellular and Molecular Medicine 25:24, pages 11053-11062.
Crossref
Bo Liang & Ning Gu. (2021) Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials. Frontiers in Cardiovascular Medicine 8.
Crossref
Meizhong Peng, Meiling Yang, Yan Lu, Shan Lin, Huajian Gao, Lingling Xie, Bin Huang, Daxin Chen, Aling Shen, Zhiqing Shen, Jun Peng & Jianfeng Chu. (2021) Huoxin Pill inhibits isoproterenol-induced transdifferentiation and collagen synthesis in cardiac fibroblasts through the TGF-β/Smads pathway. Journal of Ethnopharmacology 275, pages 114061.
Crossref
Liangping Zhao, Li Wang, Daimin Zhang, Yuqi Chen & Fulu Jin. (2021) Puerarin alleviates coronary heart disease via suppressing inflammation in a rat model. Gene 771, pages 145354.
Crossref
Zhiqing Shen, Aling Shen, Xiaoping Chen, Xiangyan Wu, Jianfeng Chu, Ying Cheng, Meizhong Peng, Youqin Chen, Nathaniel Weygant, Meizhu Wu, Xiaoying Lin, Jun Peng & Keji Chen. (2020) Huoxin pill attenuates myocardial infarction-induced apoptosis and fibrosis via suppression of p53 and TGF-β1/Smad2/3 pathways. Biomedicine & Pharmacotherapy 130, pages 110618.
Crossref
Bailu Duan, Lintao Han, Shuping Ming, JingJing Li, Qiong Wang, Dongning Zhang, Guangyu Tian & Fang Huang. (2020) Fuling-Guizhi Herb Pair in Coronary Heart Disease: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-10.
Crossref
Anika Niambi Al-Shura. 2020. Inquiry, Treatment Principles and Plans in Integrative Cardiovascular Chinese Medicine. Inquiry, Treatment Principles and Plans in Integrative Cardiovascular Chinese Medicine 81 86 .